4.5 Article

Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex

期刊

出版社

NATURE RESEARCH
DOI: 10.1038/s41594-020-00553-7

关键词

-

资金

  1. National Natural Science Foundation of China [92057101]
  2. Natural Science Foundation of Guangdong Province of China for Distinguished Young Scientists [2019B151502047]
  3. Guangdong Innovation Research Team Fund [2016ZT06S172]

向作者/读者索取更多资源

The study presents high-resolution cryo-EM structures of human SPT complex and SPT-ORMDL3 complex, revealing the basis for their assembly and substrate selectivity. These structures provide important insights for understanding sphingolipid homeostasis and development of related therapeutic drugs.
Human serine palmitoyltransferase (SPT) complex catalyzes the initial and rate-limiting step in the de novo biosynthesis of all sphingolipids. ORMDLs regulate SPT function, with human ORMDL3 being related to asthma. Here we report three high-resolution cryo-EM structures: the human SPT complex, composed of SPTLC1, SPTLC2 and SPTssa; the SPT-ORMDL3 complex; and the SPT-ORMDL3 complex bound to two substrates, PLP-l-serine (PLS) and a non-reactive palmitoyl-CoA analogue. SPTLC1 and SPTLC2 form a dimer of heterodimers as the catalytic core. SPTssa participates in acyl-CoA coordination, thereby stimulating the SPT activity and regulating the substrate selectivity. ORMDL3 is located in the center of the complex, serving to stabilize the SPT assembly. Our structural and biochemical analyses provide a molecular basis for the assembly and substrate selectivity of the SPT and SPT-ORMDL3 complexes, and lay a foundation for mechanistic understanding of sphingolipid homeostasis and for related therapeutic drug development. Cryo-EM structures of serine palmitoyltransferase complexes mediating a key reaction of sphingolipid biosynthesis elucidate principles of its multimeric assembly, regulation and substrate selectivity

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据